recent clinical studies indicate that disodium cromoglycate ( dscg ) may have a direct effect on inflammatory cells because the drug reversed various changes in leukocyte function , such as increased membrane-receptor expression and enhanced cytotoxic capacity observed in peripheral white blood cells from subjects with asthma undergoing allergen-inhalation challenge .
C0012694
disodium cromoglycate
C0004096
asthma